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Long-Lasting Spinal Oxytocin Analgesia Is Ensured by the
Stimulation of Allopregnanolone Synthesis Which
Potentiates GABAA Receptor-Mediated Synaptic Inhibition
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Hypothalamospinal control of spinal painprocessingbyoxytocin (OT)has receiveda lot of attention in recent yearsbecauseof its potency
to reduce pain symptoms in inflammatory and neuropathic conditions. However, cellular and molecular mechanisms underlying OT
spinal antinociception are still poorly understood. In this study,weusedbiochemical, electrophysiological, andbehavioral approaches to
demonstrate that OT levels are elevated in the spinal cord of rats exhibiting pain symptoms, 24 h after the induction of inflammationwith
an intraplantar injection of -carrageenan. Using a selective OT receptor antagonist, we demonstrate that this elevated OT content is
responsible for a tonic analgesia exerted on both mechanical and thermal modalities. This phenomenon appeared to be mediated by an
OT receptor-mediated stimulation of neurosteroidogenesis, which leads to an increase in GABAA receptor-mediated synaptic inhibition
in lamina II spinal cord neurons. We also provide evidence that this novel mechanism of OT-mediated spinal antinociception may be
controlled by extracellular signal-related protein kinases, ERK1/2, after OT receptor activation. The oxytocinergic inhibitory control of
spinal pain processing is emerging as an interesting target for future therapies since it recruits severalmolecularmechanisms, which are
likely to exert a long-lasting analgesia through nongenomic and possibly genomic effects.
Introduction
Oxytocin (OT) is a nonapeptide synthetized by neurons located
in the paraventricular (PVN) and supraoptic nuclei of the hypo-
thalamus (Gimpl and Fahrenholz, 2001). If the neuroendocrine
role of OT on the reproductive system is well known, its action as
a neurotransmitter is yet to be understood. Oxytocinergic neu-
rotransmission is ensured by parvocellular neurons of the PVN
projecting to several regions of the CNS, including the spinal
cord. In this particular region, there is a remarkable coexistence
of OT-positive synaptic terminals (Saper et al., 1976; Swanson
and McKellar, 1979; Sofroniew et al., 1981; Cechetto and Saper,
1988) and of OT binding sites in the most superficial layers of
the dorsal horn and in autonomic nuclei (Reiter et al., 1994;
Ve´ronneau-Longueville et al., 1999). In good agreement with
these anatomical data,OT seems to exert a potent antinociceptive
action during spinal pain processing. Local application of OT or
its endogenous release following PVN stimulation strongly re-
duces action potential firing of second-order neurons after re-
cruitment of nociceptive-specific C and A sensory neurons
(Conde´s-Lara et al., 2003, 2006). OT-induced inhibition of noci-
ceptive processing is further supported by the reduced glutama-
tergic transmission at sensorispinal synapses (Robinson et al.,
2002), which contributes for a large part to short-lasting hyper-
excitability (windup responses) and long-lasting plastic changes
(long-term potentiation) in this preparation (Conde´s-Lara et al.,
2006; DeLaTorre et al., 2009). Using patch-clamp recordings of
lamina II neurons in spinal cord slices, we recently proposed OT
action to be produced by a tonic synaptic release of GABA and by
the inhibition of voltage-gated potassium currents responsible
for repetitive firing in a subset of spinal neurons (Breton et al.,
2008, 2009). These molecular mechanisms, and possibly others
still unidentified, are likely to be recruited in inflammatory and
neuropathic pain states since OT displayed significant analgesia
in several rodent models (Lundeberg et al., 1993; Petersson et al.,
2001; Yu et al., 2003; Conde´s-Lara et al., 2005;Miranda-Cardenas
et al., 2006; Martínez-Lorenzana et al., 2008).
At this stage, results from our laboratory and other groups
show that OT action on the excitability of superficial dorsal horn
spinal neuron is potent, long-lasting, and particularly difficult to
reverse (Breton et al., 2008, 2009; DeLaTorre et al., 2009). The
major molecular target involved in OT-induced spinal antinoci-
ception is constituted by GABAA receptor channels (GABAARs)
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but nothing is known on how OT can exert long-term antinoci-
ception and if OT can be tonically released by hypothalamospinal
axons in pain conditions. To answer these questions, we used rats
exhibiting inflammatory pain symptoms 24 h after an intraplan-
tar injection of -carrageenan to measure the associated changes
in spinal OT concentrations. Because these concentrations were
elevated in hyperalgesic rats, we then characterized how these
changes affect spinal nociceptive processing and the expres-
sion of pain symptoms. Eventually, a possible long-lasting
action on GABAA receptor-mediated synaptic transmission
was investigated.
Materials andMethods
Carrageenan model of pain
Male Sprague Dawley rats (9–11 weeks, 250–350 g; Janvier) were used
for this part of the study. They were housed by group of four below
standard conditions (room temperature, 22°C; 12 h light/dark cycle)
with ad libitum access to food and water. All animals were habituated to
the room and handled by the experimenter for at least 2 weeks. After this
period, a single intraplantar injection (150 l) of -carrageenan (3% in
NaCl 0.9%; Sigma) was performed in the plantar surface of the right
hindpaw for behavioral experiments whereas injections in both hind-
paws were done for electrophysiological and biochemical studies. Con-
trol animals received an injection of NaCl 0.9% or no injection. All
experiments were conducted in conformity with the directive of the Eu-
ropean Committee Council Direction of September 22, 2010 (2010/63/
EU) and with a protocol agreement given by French Department of
Agriculture (License No. 67–116 to PP). Carrageenan model of inflam-
matory sensitization and the associated intrathecal procedures were sub-
mitted and approved by the regional ethic committee for animal
experimentation (CREMEAS authorization numbers AL 11/14/03/07
and AL 04/13/05/08).
Oxytocin radioimmunoassay
Tissue preparation. The 9- to 11-week-old male Sprague Dawley rats
(Janvier)were deeply anesthetizedwith amixture of ketamine (75mg/kg,
i.p.) and xylazine (5 mg/kg, i.p.). They were killed 24 h after the bilateral
injection of -carrageenan (carrageenan group: n  5) or saline injec-
tions (saline group: n  5). Five control rats (not injected) of the same
weight were added to the study. The spinal cord of each rat was collected
by hydraulic extrusion and cut in slices 1 mm thick by a tissue chopper
(McIlwain). To limit degradation of the peptides, slice cutting and sam-
ple preparation was performed on melting ice. Spinal cord slices, placed
in tubes containing 60l of HCl (0.1 N), were sonicated for 30 s, and the
resulting homogenate was centrifuged 15 min at 12,000 rpm. OT dosage
was realized in 5 l aliquot fractions of the supernatant.
OT assay. The principle of the assay is based on the competition be-
tween endogenous unlabeled OT and exogenously supplied iodine-125
radiolabeled OT (125I-OT) for a specific antibody directed against OT
(Moos et al., 1984). 125I-OT was produced in the laboratory by redox
reaction between OT and 125I-Na, catalyzed by lactoperoxidase and hy-
drogen peroxide (Moos et al., 1984). The product of this reaction was
purified by HPLC. For each sample, incubations were performed with
100 l of spinal cord extract (unknown concentration of OT), 100 l of
antiserum (diluted to give 50% of iodinated hormone bound with the
antibody in the absence of antigen), and 100l of 125I-OT (1000 counts/
min per tube). All dilutions were made in a barbital buffer (0.05 M so-
dium barbital, pH 8.6, 2.5 mg/l bovine serum albumin, and 0.02%
sodium merthiolate). After a 6 d incubation at 4°C, bound and free
hormone were separated by charcoal adsorption and then by adding 100
l of bovine serum and 1 ml of charcoal-dextran suspension (Charcoal
Norit C 170, Fisher Scientific; Dextran T70, Pharmacia). Suspension was
centrifuged at 800 rpm for 20min at 4°C and the supernatant containing
the OT-antibody complexes was discarded; the 125I-OT retained by the
charcoal suspension was quantified by a gamma counter (Packard) and
compared with standard displacement curves obtained with known con-
centration of OT. OT content is expressed in pg/mm of spinal cord and
the vertebral level was identified before cutting.
FosB/FosB immunohistochemistry
Immunohistochemistry was performed on a separate set of animals (n
6 per group). One day following intraplantar injection of either carra-
geenan or saline solution, rats were perfused intracardially with 150ml of
PB (0.1 M, pH 7.4) followed by 500 ml of a solution containing 4%
paraformaldehyde in PB. After laminectomy, the lumbar spinal cord
(L3–L5) segments were collected, immersed overnight in the same fixa-
tive, and washed the next day in phosphate saline buffer (PBS). Trans-
verse sections of 40 m were prepared using a tissue slicer (Leica
VT1000S). The sections were rinsed three times during 10 min in PBS
and subsequently incubated for 1 h in a blocking solution composed of
5%donkey serum in PBS and 0.5%Triton X-100. The sections were then
incubated overnight with a “pan-FosB” antibody (rabbit polyclonal
1:1000, ref. sc-48; Santa Cruz Biotechnology) raised against an internal
region of FosB (i.e., recognizing both FosB andFosB proteins) andwith
neurophysin-OT (1:250; kindly provided by Dr. Pierre Veinante, Uni-
versity of Strasbourg, Strasbourg, France) diluted in PBS containing 1%
normal serum and 0.5% Triton X-100. After washing with PBS (5 10
min), the sections were incubated 90 min with the secondary antibodies
(Cy3:1:800, FITC: 1:80; Sigma-Aldrich) for 2 h at room temperature.
After rinsing with PBS (3 10 min), sections were mounted on gelatin-
coated slides. Three sections per animal were randomly chosen and the
number of activated neurons (FosB) and of OT-positive cells
(neurophysin-OT) in the paraventricular nucleus was assessed.
Electrophysiological recordings
Single-unit extracellular recording of dorsal horn spinal neurons in vivo.
The 9- to 11-week-old Sprague Dawley rats were anesthetized with 3%
isoflurane in pure oxygen and a laminectomy was performed to expose
the L4–L5 spinal cord segments. The animal was then placed on a stereo-
taxic frame, with the L4–L5 exposed region being firmly held by two
clamps placed on the apophysis of the rostral and caudal intact vertebras.
Isoflurane anesthesia was then reduced to 1.5% and a stainless steel elec-
trode (10 M; FHC) was lowered in the dorsal horn of the spinal cord
after meninges removal. Single-unit extracellular recordings were all
made from deep dorsal horn neurons, located 400–800 m from the
dorsal surface (see Fig. 1B), receiving convergent (non-noxious and nox-
ious) sensory information from the ipsilateral hindpaw as previously
described (Juif and Poisbeau, 2013). Voltage changes were amplified and
filtered (low: 300 Hz; high: 3000 Hz) by a DAM-80 differential amplifier
(WPI). Recordings were acquired at 10 kHz and analyzed using the Spike
2 software, collecting data through a CED 1401 analog-to-digital inter-
face (Cambridge Electronic Design). The stimulating threshold to evoke
action potentials and their frequency of occurrence, resulting from the
stimulation of the peripheral receptive field on the rat hindpaw, were
attributed to the recruitment of A- and C-type sensory fibers based on
their latency from the stimulus artifact as follows: A: 20 ms; A:
20–90 ms; C: 90–300 ms; post discharge: 300–800 ms. Modulation of
spinal cord neuron excitability was determined on action potential firing
responses induced by electrical stimuli of the hindpaw (1 ms pulse dura-
tion, frequency 0.2 Hz), at an intensity corresponding to 1.5 times the
threshold for C-type sensory fiber activation.
Patch-clamp recording of lamina II neurons in spinal cord slices. Trans-
verse slices of lumbar spinal cord were prepared from young adult
Sprague Dawley rats (P21–P55; Janvier) deeply anesthetized with a mix-
ture of ketamine (75 mg/kg, i.p.) and xylazine (5 mg/kg, i.p.), as de-
scribed in previous studies (Keller et al., 2001). Although animals were
younger than those used for the OT dosage, pain behavior, and in vivo
electrophysiology, we found no difference in the synaptic current char-
acteristics while recording from neurons in spinal cord slices of P21 rats
and older animals (maximum age P55). This observation was in agree-
ment with our previous observation (Keller et al., 2001) and data were
pooled. Animals were killed 24 h after having performed the carrageenan
or saline (bilateral) hindpaw injections. The lumbar spinal cord was
collected by hydraulic extrusion and placed into ice-cold sucrose artifi-
cial CSF (S-ACSF) containing the following (in mM): 248 sucrose, 11
glucose, 23 NaHCO3, 2 KCl, 1.25 KH2PO4, 2 CaCl2, and 1.3 MgSO4 and
was continuously saturatedwith 95%O2–5%CO2. Transverse slices (300
m thick) were cut from the lumbar segment of the spinal cord using a
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vibratome and stored at room temperature in an incubation chamber
filled with regular ACSF containing the following (in mM): 126 NaCl, 26
NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 2 CaCl2, 2 MgCl2, and 10 glucose and
continuously saturated with 95% O2–5% CO2. Spinal cord slices were
stored for at least 1 h at room temperature before being placed into the
recording chamber. The slices were continuously superfused with oxy-
genated ACSF at a flow rate of3 ml/min.
All electrophysiological experiments were performed at room temper-
ature in regular ACSF and lamina II neurons were recorded using the
whole-cell configuration of the patch-clamp technique. The patch pi-
pette was filled with a solution containing the following (in mM):
125 CsCl, 2 MgCl2, 2 Mg-ATP, 0.2 Na-GTP, and 10 HEPES, pH, 7.3
adjustedwith CsOH.Neurons were voltage clamped at60mVusing an
Axopatch 200B amplifier (Molecular Devices); series capacitance (Cs)
and resistance were (Rs) compensated electronically throughout the ex-
periments and only recordings lasting longer than 20 min with series
resistance 20 M were considered for analysis. All recordings were
low-pass filtered at 5 kHz, digitized at 10 kHz, and stored on computer
using the Clampex module of pClamp software (Molecular Devices)
before being analyzed. GABAA receptor-mediated miniature IPSCs
(GABAAR mIPSCs) were pharmacologically isolated by using an ACSF
containing 0.5M tetrodotoxin (Latoxan), 2mM kynurenic acid (Fluka),
and 1 M strychnine (Sigma). Off-line, GABAAR mIPSCs were detected
and analyzed individually usingWinEDR andWinWCP software (cour-
tesy of Dr. J. Dempster, University of Strathclyde, Glasgow, UK) to ex-
amine their frequency of occurrence, amplitude, and monoexponential
decay time constants ().
Allopregnanolone dosage
Transverse slices of lumbar spinal cord were prepared from Sprague
Dawley rats (between 30 and 50 d old; Janvier) anesthetized with a mix-
ture of ketamine (75 mg/kg, i.p.) and xylazine (5 mg/kg, i.p.). Slices (1
mm length) were then placed for 3 h at room temperature in an incuba-
tion chamber filled with regular ACSF (see above) supplied with either
[Thr4,Gly 7]-oxytocin (TGOT; 1 M) or TGOT (1 M)  d(CH2)5-
[Tyr(Me)2,Thr4,Orn8,des-Gly-NH2
9-vasotocin (dOVT; 1 M) continu-
ously saturated with 95% O2–5% CO2. After this incubation period,
sections were homogenized in 200 l of ultrapure water and 600 l of
methanol (100%) were added. Samples were centrifuged during 30 min
at 14,000  g (4°C). Then, supernatant was recovered and dried with a
SpeedVac evaporator. Sample extracts were dissolved in 200l of ELISA
sample buffer before quantification. An allopregnanolone-ELISA kit
(GENTAUR) was used to quantify allopregnanolone concentrations in
spinal cord extracts (50 l in duplicate) following the manufacturer’s
instructions. For all tests, allopregnanolone standards were diluted in the
sample buffer to avoid matrix effects. The coefficient of variation (CV)
values were between 0 and 8%. All samples with a higher CV value were
tested again to obtain a CV below or equal to 8%. The calculated meth-
odological detection limit of the batch of ELISA kit used for the studywas
1 ng/ml of allopregnanolone. Amounts of allopregnanolone (ng) were
normalized according to protein’s concentrations (Protein Assay;
Bio-Rad) determined before the extraction procedure. Note that
cross reactivity of the antibody is 15% for progesterone and 17-
hydroxyprogesterone (source: manufacturer) and 10.9% for allotet-
rahydrodeoxycorticosterone (present study).
Behavioral testing
Habituated adult Sprague Dawley rats (n  6 per group) were used to
measure nociceptive thresholds while applying mechanical and thermal
heat stimuli on their hindpaws. All behavioral tests were done during the
light period (between 9:00 and 16:00). Mechanical sensitivity was mea-
sured using a calibrated forceps (Bioseb) previously validated in our
laboratory (Luis-Delgado et al., 2006). Briefly, the rat was loosely re-
strained with a towel masking the eyes to limit stress by environmental
stimulation. The tips of the forceps were placed on each side of the
hindpaw and a gradually increasing force was applied. The pressure pro-
ducing paw withdrawal indicated the nociceptive threshold value. The
thermal heat nociceptive response was assessed using Hargreaves’ test
(Bioseb), allowing the differentiation of the response of each hindpaw
(Hargreaves et al., 1988). Hindpaws are exposed to a radiant heat and the
latency time required to induce pawwithdrawal from the surface is taken
as the nociceptive heat threshold. Nociceptive pressure threshold or
withdrawal latency measurements were performed three times for each
hindpaw and the values were averaged.
Drugs and treatments
Weused the selectiveOT receptor agonist TGOT (Sigma) and antagonist
dOVT (Bachem). OT receptors ligands were prepared as 1000 stock
solutions in a molar acetic acid solution 0.25% (v/v) in distilled water.
These drugswere then added to theACSF for in vitro electrophysiological
experiments and to saline solution for behavioral experiments and in vivo
electrophysiological recordings. The vehicle, used to prepare stock solu-
tions and diluted at least 1000 times, had no electrophysiological or
behavioral effects in the present study. To block neurosteroidogenesis in
vitro, we incubated spinal cord slices	3 h in oxygenated ACSF contain-
ing PK11195 [1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-iso-
quinoline carboxamide: an inhibitor of the cholesterol translocator
protein complex (TSPO; Steraloids)] and finasteride [1,(5)-androsten-
4-aza-3-one-17-(N-tert-butyl-carboxamide): an inhibitor of type II
5-reductase (Steraloids)]. In such experiments, the control condition
consisted of adjacent slices incubated under the same conditions but in
the absence of the pharmacological agents. In vivo, rats received a subcu-
taneous injection (scapular region), every 2 d, of finasteride (FIN; 30
mg/kg) or Depo-Provera (4-pregnen-6-methyl-17-ol-3, 20-dione ace-
tate: inhibitor of 3-hydroxysteroid dehydrogenase; 5mg/kg; Steraloids)
prepared in an olive oil vehicle with 20% v/v ethanol. Treatment was
administered for at least 1 week before -carrageenan injection and until
the end of the behavioral testing. To inhibit the activity of ERK1/2 in
vitro, we incubated spinal cord slices in ACSF containing 20MPD09859
(Merck-Millipore). With an IC50 of 2 M, an inhibition of90% of the
ERK1/2 activity is likely to be achieved while using a steady-state concen-
tration of 20 M (Alessi et al., 1995).
Intrathecal injections
Oxytocin receptor agonist (TGOT) and antagonist (dOVT) were admin-
istered intrathecally on rats, anesthetized with halothane 3% (in pure
oxygen). Acute intrathecal injection was realized by puncture through
the intervertebral space between L5 and L6 using a 50 l Hamilton mi-
crosyringe with a 26 gauge needle. A characteristic tail flick indicated
penetration of the needle in the intrathecal space and ensures success for
the delivery of the drug. After injection of the drug solution or of the
vehicle (NaCl 9‰; 10l), the animal immediately recovered from halo-
thane anesthesia and was placed in the testing chamber. To estimate
possible spinal effect of the neurosteroids, rats were tested formechanical
thermal nociception 1, 4, and 24 h after the intrathecal injection, to check
for recovery.
Statistical analysis
All data are expressed as mean 
 SEM. One-way or two-way ANOVA
were used to analyze the effects of treatments (between factors), of side
(between factors), and of time (within factor). Significant differences
were assessed using Tukey’s or Bonferroni post hoc tests (Statistica; Stat-
Soft). Differences were considered to be statistically significant for p 
0.05. Kolmogorov–Smirnov test (KS test) was used to compare cumula-
tive distributions and they were considered different when p  0.01.
Two-tailed paired and unpaired Student’s t tests and nonparametric
Mann–Whitney test were also used to compare two or more groups.
Differences were considered to be statistically significant for p 0.05.
Results
Increased spinal OT content exerts a tonic inhibitory control
of spinal nociceptive processing in carrageenan-injected
animals
OT content from rat spinal cord was quantified by radioimmu-
noassay (RIA) 24 h after a bilateral intraplantar injection of
-carrageenan and compared with the control groups: vehicle-
injected (saline) and not injected (naive). In naive (n  5 rats)
and saline-injected rats (n  5), OT content was similar for all
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spinal cord vertebral segments and was
70 pg/mm of spinal cord. However, spi-
nal OT content peaked at thoracic levels
T2–T4 (Control: 103.3
 5.8 pg/mm; Sa-
line: 98.8 
 7.7 pg/mm; data not shown)
and at lumbar levels L1–L2 and L5–L6
(Fig. 1A). In carrageenan-injected rats
(n  5), OT content was similar to the
corresponding level of control and saline-
injected groups but concentrations were
significantly higher at most lumbar seg-
ments (L1–L2, L4–L6) with the Tukey
post hoc test (Fig. 1A) after having per-
formed an ANOVA between the different
groups (two-way ANOVA, interaction
between treatment and spinal cord seg-
ment: F(28,180) 13.59, p 0.001).
Because oxytocinergic neurons, pro-
jecting to the spinal cord, are mostly lo-
cated in the paraventricular nuclei, we
next verified if the observed release of OT
following carrageenan-induced inflam-
mation resulted from the activation of
these neurons. This was done by quantify-
ing the number of activated oxytocinergic
neurons using a double staining for
neurophysin-OT and FosB/FosB after
carrageenan or saline intraplantar injec-
tion (Fig. 1A, inset). As expected, the total
number of FosB/FosB-immunoreactive
cells in the PVN was significantly increased
in carrageenan-treated animals (41.7
 2.0,
n  4) compared with noninflamed ani-
mals (1.6 
 0.5, n  4; Mann–Whitney,
p 0.001). Interestingly, this was also true
while counting neurophysin-OT-immuno-
positive neurons (control: 9.0 
 1.0; carra-
geenan: 65.9 
 4.6; Mann–Whitney, p 
Figure 1. Elevated lumbar content in OT accounts for a limitation of spinal nociceptive processing in the carrageenanmodel of
inflammatory pain sensitization.A, OT contentmeasured in thoracolumbar spinal vertebral segments (from T9 to S4) of naive (not
injected, open squares), saline-injected (open circles), and carrageenan-injected (filled circles) animals. Twenty-four hours after
4
the injection, carrageenan animals had significantly higher OT
content in L1, L2, L5, and L6 vertebral segments compared
withnaive and saline-injected animals. (Asterisks indicate sta-
tistical difference after Tukey’s post hoc test within each spinal
cord segment.) Inset, Histogram illustrating thenumber ofOT-
neurophysin-positive neurons in the PVN also labeled for
FosB/FosB in control (saline: white bar) and carrageenan-
injected rats (black bar). B, Representative in vivo recording
from a carrageenan-injected rat (24 h after the injection)
showing typical evoked action potential responses of a deep
dorsal horn neuron located in the lumbar enlargement, after
the stimulation of the corresponding ipsilateral hindpaw re-
ceptive field. Note that local application of the OT receptor
antagonist dOVT (1 M) induced a strong increase in firing
frequency (see expended traces in the middle). On the right is
indicated the location of recorded neurons. C, Histogram illus-
trating changes in the number of action potentials per period
of 10 min (stimulation at 0.2 Hz), before and after application
of dOVT, for the neuron illustrated in B. For all recorded neu-
rons (n 8), the mean number of action potentials per PAF
type [A, A, C, and post discharge (PD)] is also illustrated in
the inset. Statistical difference was assessed between groups
using two-tailed paired Student’s t test. *p 0.05; **p
0.01; ***p 0.001.
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0.001) fully in agreementwith ourRIAdata.Weobserved that the
number of colocalized OT/FosB neurons (Fig. 1A, inset) was sig-
nificantly higher in carrageenan-injected rats (26.7
 1.5, n 4)
compared with control animals (0.4
 0.2, n 4; Mann–Whit-
ney, p 0.001). We next answered the question of what could be
the functional consequences of the elevatedOT spinal content on
spinal nociceptive processing and GABAAR-mediated inhibitory
synaptic transmission.
We first recorded dorsal horn neuron responses after the elec-
trical stimulation of the hindpaw receptive field. We choose to
record wide dynamic range neurons (WDR; Fig. 1B), which in-
tegrate convergent peripheral sensory information from non-
nociceptive A type and nociceptive A and C-type primary
afferent fibers (PAFs). Local spinal application of an OT
receptor-antagonist, dOVT, was performed to reveal a possible
effect of endogenous OT on inhibitory tone in saline- and
carrageenan-injected rat. In saline-injected animals (and also in
naive; data not shown), local lumbar dOVT application (1 M)
had no obvious effect on deep dorsal horn neurons excitability in
response to the activation of fast and slow conducting PAFs
(number of action potentials as well as PAF thresholds were un-
changed; data not shown, n 6). In contrast, C-type PAF thresh-
old was significantly decreased in carrageenan-injected rats
(1.38 
 0.10 mA, n  8) compared with the control group
(2.11
 0.71mA,n 8; unpaired Student’s t test: t(14) 1.02, p
0.05), and this thresholdwas further decreased to 0.91
 0.06mA
(n  8) after topical application of dOVT on the spinal cord
compared with value before dOVT (paired Student’s t test: t(7)
5.95, p  0.001). In addition, a train of 120 stimulations (fre-
quency: 0.2 Hz, intensity 1.5 times the C-type fiber threshold;
pulse duration: 1 ms) was used to quantify the number of action
potentials emitted by the recorded neuron. As illustrated in Fig-
ure 1, B and C, a significant increase in the number of action
potentials, resulting from the stimulation of C-type PAFs (post
discharge included), was observed in carrageenan-injected rats
after spinal application of dOVT (before dOVT: number of ac-
tion potentials  444 
 42; after dOVT: number of action po-
tentials 703
 56; n 8; t(7) 6.621 paired Student’s t test: p
0.01), whereas the response to A-type PAF activation was not
affected during spinal application of dOVT (Fig. 1C; see also
Table 1). In a subset of experiment we further demonstrated that
25% of the recorded WDR neurons (n  20) were projecting
neurons since they displayed a retrograde action potential after
stimulation of the anterolateral spinal quadrant (intensity: 200
A, pulse duration: 100 s), a few millimeters rostrally to the
recording site. All together, these results show that peripheral
inflammation induced by injection of carrageenan in the hind-
paw increases OT content at the spinal lumbar level and this
release of OT exerts a tonic inhibition of nociceptive C-type PAFs
converging directly or indirectly on WDR neurons. Since all
WDR neurons were submitted to this inhibitory action of OT
(i.e., including projection neurons), we suggest here that su-
praspinal transmission of peripheral nociceptivemessages will be
reduced.
Long-term activation of OT receptor potentiates fast
GABAergic synaptic transmission
To better understand how spinal OT could exert long-lasting
antinociceptive effects in the neuronal networks of the spinal
cord, we next incubated spinal cord slices from naive rats for at
least 3 h at room temperature in regular ACSF or in ACSF con-
taining 100 nM TGOT, a selective OT receptor agonist. Then,
GABAAR mIPSCs were recorded from neurons in lamina II,
which represent a major target for nociceptive C-type PAFs. Am-
plitude, frequency of occurrence, rise time, and decay time con-
stant of GABAAR mIPSCs were analyzed (see Materials and
Methods). Compared with the control condition, GABAAR
mIPSCs recorded after TGOT incubation differed only by their
decaying kinetics (Fig. 2A,D, Table 2; one-wayANOVA: F(4,34)
15.36, p  0.001). The mean monoexponential decay time con-
stant ()was significantly slower comparedwith control (control:
20.4
 1.5ms, n 8; TGOT: 32.5
 2.3ms, n 9; Tukey post hoc
test: p  0.001). Interestingly, prolonged mIPSCs were never
observed when spinal cord slices were incubated in the presence
of TGOT (100 nM) and dOVT (1 M; Table 2, Fig. 2A,D; Tukey
post hoc test: p	 0.05). All together, these results strongly support
the idea that endogenously released OT exerts a tonic inhibitory
control on lamina II neurons mediated by a potentiation of
GABAAR-mediated synaptic tone.
OT long-lasting potentiation of GABAAmIPSCs is achieved
by the stimulation of allopregnanolone synthesis: possible
role of extracellular signal-regulated kinases
Our laboratory has provided evidence indicating that endoge-
nous neurosteroids are produced in the spinal cord after periph-
eral inflammation induced by intraplantar injection of
carrageenan. In particular, the spinal synthesis of 35-reduced
neurosteroids limits the intensity of pain symptoms by potenti-
ating GABAergic transmission in lamina II interneurons (Pois-
beau et al., 2005). In good agreement with our previous findings
and compared with control (saline injected), GABAAR mIPSCs
recorded from lamina II spinal cord neurons of hyperalgesic rats
(24 h after carrageenan intraplantar injection) exhibited a signif-
icant prolonged decaying phase (control:  20.4
 1.2 ms, n
9; carrageenan:   30.7 
 1.2 ms, n  12; one-way ANOVA:
F(4,46) 25.06, p 0.001; Tukey post hoc test: p 0.001; Fig. 2D).
No differences were noted for the other parameters, i.e., mean
amplitude, rise time, and frequency of occurrence (data not
shown). Interestingly, GABAARmIPSCs recorded from lamina II
neurons during hyperalgesia were similar to those recorded from
TGOT-incubated lamina II neurons of naive rats (Fig. 2D; TGOT
incubation:  32.5
 2.3 ms, n 9; carrageenan injection: 
30.7 
 1.2 ms, n  12). Furthermore, inhibition of 35-
reduced neurosteroid synthesis by subcutaneous injection of
finasteride (FIN: 5-reductase inhibitor; 30 mg/kg every 2 d; Fig.
2B–D), 1 week before the injection of carrageenan in the hind-
paw, fully occluded the increase in GABAAR mIPSC decays,
which were similar to the control group (Tukey post hoc test: p	
0.001; Fig. 2B,D).
To reveal a possible oxytocinergic control of neurosteroido-
genesis, we next incubated spinal cord slices of naive rats for 3 h in
ACSF containing TGOT (100 nM) and two inhibitors of neuros-
teroidogenesis (Fig. 2C): the 5-reductase inhibitor finasteride
(50 M) and the mitochondrial TSPO inhibitor PK11195 (10
Table 1. Action potential firing of WDR neurons recorded from the spinal cord of
carrageenan-induced hyperalgesic rats
Treatment A A C
Post
discharge N
Control 264
 20 145
 45 486
 106 248
 91 8
dOVT, intrathecal. 289
 17 179
 46 693
 108** 361
 95 8
Deep dorsal horn neuron action potential responses to electrical stimulation of the hindpaw (see Materials and
Methods) are classifiedbasedon their latency to the stimulationas follows:A:20ms;A: 20–90ms; C: 90–300
ms; post discharge: 300–800ms. Results were obtained from carrageenan-injected rats before (Control) and after
local spinal dOVT application. Values are indicated asmean
 SEM Statistical significancewas assessed by compar-
ing the groups before and after dOVT using two-tailed paired Student’s t test (**p 0.01).
Juif, Breton et al. •Mechanisms of Spinal Oxytocin Analgesia J. Neurosci., October 16, 2013 • 33(42):16617–16626 • 16621
M). Inhibition of spinal neurosteroidogenesis in vitro occluded
the effect of TGOT incubation on the decay of GABAARmIPSCs
(Table 2, Fig. 2B,D; one-way ANOVA: F(4,34) 15.36, p 0.001;
Tukey post hoc test: p	 0.05). This result strongly suggested that
spinal OT receptor activation is required for the potentiation of
GABAAR mIPSCs by locally produced 35-reduced neuros-
teroids. This conclusion was further supported by the quantifica-
tion of allopregnanolone in lumbar spinal cord sections
incubated for 3 h in TGOT alone or TGOT  dOVT. Allopreg-
nanolone levels were 0.11 
 0.04 ng/mg protein (n  10) after
TGOT incubation but significantly lower and barely detectable
after TGOTdOVT (0.02
 0.03 ng/mgprotein, n 10;Mann–
Whitney, p 0.01).
Although OT receptor-mediated intracellular signaling cas-
cade is still unclear in the CNS, evidence suggests that ERKs are
likely to constitute a converging pathway. We examined this hy-
pothesis by analyzing the decaying kinetics of GABAAR mIPSCs
after a 3 h coincubation of spinal cord slices in the presence of
TGOT (1 M) and of the MEK pathway inhibitor PD09859 (20
M). Under this experimental condition, the resulting mean de-
cay time constant was of 20.6 
 0.9 ms (n  7) and similar to
control slices (incubated in regular ACSF) taken from naive rats
(p 	 0.05 Tukey post hoc test). This result likely indicated that
ERK1/2 was indeed recruited after OT receptor activation and
could account for the stimulation of neurosteroidogenesis and
the subsequent tonic potentiation of GABAAR-mediated synap-
Figure 2. OT receptor activation increases the inhibitory charge carried by synaptic GABAARs in lamina II neurons through the stimulation of 35 neurosteroids synthesis. A, B, Cumulative
probability graphs of GABAA mIPSC decay time constants () recorded in lamina II neurons of rat spinal cord slice (A) incubated 3 h in control ACSF (Naive: dotted line, n 281 events), TGOT (100
nM: thin black line, n 200 events), or TGOT and dOVT (1M; thick gray line, n 207 events) and (B) of control (not injected: dotted line, n 117 events) and carrageenan-injected animals,
pretreated with finasteride (thick gray line, n 616 events) or not (thin black line, n 414 events). Traces in A are an average of 10 individual GABAAR mIPSCs in the different experimental
conditions. Note that neurons incubated in TGOT exhibited significantly prolonged mIPSC decay time constant (compared with control, KS test, p 0.001) and this effect was occluded in slices,
incubated in the presence of TGOT and dOVT (KS test, p	 0.05). Decay time constant of GABAAR mIPSCs recorded in the carrageenan condition were also slower compared with those of control
animals (KS test, p 0.001) and of finasteride-pretreated carrageenan (KS test, p 0.001). C, Simplified schematic showing the metabolic pathway that leads to the production of 35
neurosteroids: allopregnanolone (THP) and tetrahydrodeoxycorticosterone (THDOC), two potent positive allosteric modulators of GABAA receptor function. Finasteride and PK11195 were used to
inhibit 5-reductase activity and TSPO function, respectively. D, Histogram comparing the mean decay time constants of GABAARmIPSCs recorded from lamina II neurons in various experimental
conditions: (top graph) in vitro slice incubation (3 h)with normal ACSF (control), TGOT alone (100 nM), or in combinationwith dOVT (1M), PK11195 Finasteride (PK FIN), or PD09859 (20M);
(bottomgraph) in vivopretreatmentof animalswith finasteride (30mg/kg, s.c) for 7dordOVT (10ng, intrathecally) 24hbefore carrageenan sensitization (Carra) are comparedwitha saline-injected
group (control). Traces on the right are an average of 10 individual GABAAR mIPSCs recorded from control, carrageenan, and dOVT carrageenan-treated rats. One-way ANOVAs performed to
compare treatments for in vitro and in vivo conditions were significantly different. Tukey’s post hoc test indicates significance at ***p 0.001.
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tic transmission in lamina II spinal cord neurons. This prelimi-
nary result, while interesting, will need to be consolidated by
additional investigations to fully dissect the underlying signaling
cascade, which may involve other well known kinases.
To further strengthen this conclusion, dOVT was injected in-
trathecally in the lumbar segment of the rat spinal cord (10 ng;
volume: 10l) 24 h before the intraplantar carrageenan injection.
Spinal cord slices (of the lumbar enlargement) from these rats
were then prepared, 48 h after dOVT intrathecal injection and
24 h after carrageenan intraplantar injection, to record GABAAR
mIPSCs from lamina II neurons. In good agreement with our in
vitro incubation result, lamina II neurons recorded from dOVT-
pretreated and carrageenan-injected rats exhibited GABAAR
mIPSCs similar to those recorded from the control group. In
particular, we failed to reveal any differences in the mean decay
time constant ( 20.6
 0.9ms; n 12; p	 0.05 Tukey post hoc
test; Fig. 2D). Furthermore, intrathecal injection of dOVT
(alone) in naive animals was not associated with any change in
the decay time constant of GABAAR mIPSCs (Fig. 2D; dOVT
24 h:  19.3
 1.0ms, n 9; comparedwith control, p	 0.05
Tukey post hoc test). All together, our results provide convincing
evidence that a tonic activation of spinal OT receptors modulates
GABAA inhibitory tone in carrageenan-induced pain animals in
lamina II neurons. This mechanism is ensured by a stimulated
synthesis of 35-reduced neurosteroids, which is ERK1/2 de-
pendent. We next attempted to demonstrate that this endoge-
nous mechanism could be responsible for the reduction of pain
symptoms in carrageenan-induced hyperalgesic animals.
Tonic activation of spinal OT receptor stimulates the
synthesis of 35-reduced neurosteroids and limits
mechanical and thermal heat hyperalgesia
Figure 3 illustrates the time course of mechanical (A1) and ther-
mal hot hyperalgesia (B1)measured after a unilateral intraplantar
carrageenan injection (right paw, black symbols).Whilemechan-
ical and thermal nociceptive thresholds of the noninjected paw
remained similar to the baseline values, mechanical and thermal
hyperalgesia develop rapidly for the carrageenan-injected paw
and reached its maximum 7 h after the injection (mechanical
pressure threshold decrease from 333.8
 4.9 g before the injec-
tion to 19.5 
 2.2 g; two-way ANOVA: time  treatment,
F(13,130)  76.45, p  0.001; Bonferroni: p  0.001; thermal la-
tency threshold decrease from 11.9
 0.5 s before the injection to
2.5 
 0.5 s; n  6 rats per group; two-way ANOVA: time 
treatment, F(9,81) 10.04, p 0.001; Bonferroni: p 0.001; Fig.
3A1–B1). As indicated on the time course, and especially 24 h
after carrageenan injection, rats remained hyperalgesic for me-
chanical (43%) and thermal hot modalities (54%).
We next characterized the effects of intrathecal injections of
saline, TGOT (100 nM), and dOVT (1 M) on mechanical and
thermal nociceptive thresholds, 24 h after intraplantar carra-
geenan injection. This experimentwas designed to demonstrate if
endogenous OT tonus limits the intensity of pain symptom
(dOVT intrathecal application) and if this OT-mediated antino-
ciceptive control could be further potentiated (TGOT intrathecal
application). Furthermore, TGOT and dOVT were administered
to hyperalgesic rats, pretreated for at least 1 week with neuros-
teroidogenesis inhibitors (finasteride or Provera, see Materials
and Methods) before the intraplantar carrageenan injection, to
confirm or not that OT spinal analgesia requires the synthesis of
35 neurosteroids. It has to be noticed that the finasteride or
Provera treatment did not produce any significant changes in the
nociceptive thresholds per se. In the control group of rats (intact
neurosteroidogenesis), intrathecal injection of TGOT (100 nM)
had no significant effect on mechanical and thermal nociceptive
threshold/latency (Fig. 3A2–B2, left graphs). In contrast, intra-
thecal injection of dOVT (1 M) was associated with an immedi-
ate and significant decrease in mechanical threshold (from
205.6
 23.3 g to 81.8
 3.7 g; n 6; two-way ANOVA: time
treatment, F(4,30)  7.97, p  0.001; Bonferroni: p  0.001; Fig.
3A2, left graph) and thermal hot latency (from5.8
 0.4 s to 3.2

0.5 s; n 6; two-way ANOVA: time treatment, F(4,30) 8.13,
p 0.001; Bonferroni: p 0.001; Fig. 3B2, left graph), 4 h after
intrathecal injection. As indicated in the Fig. 3, A2 and B2, exac-
erbation of mechanical and thermal hyperalgesia following
dOVT intrathecal injection was never observed in finasteride- or
Provera-pretreated rats. Our in vivo results strongly suggest that
the tonic activation spinal OT receptors in hyperalgesic rats leads
to the local production of 3-reduced neurosteroids, which limit
the intensity of their pain symptoms. Potentiation of GABAA
receptors in spinal nociceptive circuits are, for sure, a privileged
target for this endogenous inhibitory control.
Discussion
Among the very few homeostatic analgesicmechanisms that have
been identified so far in the CNS, cellular mechanisms leading to
an efficient long-lasting antinociception are largely unknown. In
this study, we have attempted to understand how the activation
of descending hypothalamospinal oxytocinergic axons could ex-
ert such a tonic inhibitory control in the spinal cord, in a rat
model of inflammatory sensitization following intraplantar car-
rageenan injection. Using different experimental approaches,
biochemical, electrophysiological, and behavioral techniques, we
show that the proinflammatory action of carrageenan in the paw
is associated with the activation of oxytocinergic neurons in the
PVN and leads to an elevation of OT spinal content, which may
account for a tonic antihyperalgesic effect. In lamina II of the
spinal cord, OT receptor activation seems to involve the recruit-
ment of ERK1/2 and the stimulation of the local synthesis of
allopregnanolone, which in turn increase GABAA receptor-
mediated inhibitory tone.
Acute OT control of spinal nociceptive processes and pain
responses is well documented and several mechanisms have been
identified to explain these effects. In previous studies, endoge-
nous OT release in the spinal cord was triggered by an electrical
stimulation of PVN neurons (Martínez-Lorenzana et al., 2008)
and produced amassive and sustained reduction in action poten-
tial firing in dorsal horn neurons (Yirmiya et al., 1990; Shiraishi et
al., 1995; Conde´s-Lara et al., 2006). This reduction is fully pre-
vented by selective OT receptor antagonist and affects selectively
nociceptive inputs carried by A and C fibers (Conde´s-Lara et al.,
Table 2. OT receptor activation potentiates GABAA receptor-mediatedmIPSCs in
lamina II neurons of the spinal cord
mIPSC parameters
Amplitude
(pA) Decay () Frequency (Hz) N
Control incubation 30.8
 3.4 20.4
 1.5 0.305
 0.047 8
TGOT 33.1
 2.5 32.5
 2.3* 0.259
 0.036 9
TGOT dOVT 33.0
 1.2 19.4
 1.1 0.322
 0.046 7
dOVT incubation 32.5
 1.0 21.3
 0.5 0.321
 0.030 10
TGOT PK11195 finasteride 35.6
 1.2 17.7
 1.2 0.444
 0.076 8
Characteristics of GABAAR mIPSCs recorded from lamina II neurons of rat spinal cord after a 3 h incubation in
the following solutions: control (regular ACSF), TGOT (100 nM), TGOT (100 nM) dOVT (1M), dOVT (1M),
and TGOT (100 nM)  PK11195 (10 M)  finasteride (50 M). Values are indicated as mean 
 SEM
Statistical significance between treatments was observed by one-way ANOVA only in the case of decay.
Tukey’s post hoc tests indicated a statistical difference for decay time constants of mIPSCs recorded from the
TGOT-incubated spinal cord slices (*p 0.05).
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2006; Miranda-Cardenas et al., 2006). Many lines of evidence
indicate that acute spinal OT analgesia is associated with a rein-
forcement of GABA receptor-mediated inhibition. In a recent
study, we proposed that oxytocinergic control is relayed by a
subset of glutamatergic neurons in lamina II, which recruit most,
if not all, GABAergic interneurons (Breton et al., 2008). This
hypothesis is supported by the elevated frequency of spontane-
ously occurring GABAA IPSCs, but not of miniature events.
Whether this increase in GABAA receptor-mediated synaptic
transmission is responsible for the inhibition of glutamatergic
sensorispinal synapses (presynaptic inhibition) and/or of second-
order spinal neuron integration is still unclear (Robinson et al.,
2002). In all cases, OT action results in a strong reduction of
spinal pain processing and this might also involve changes in the
integration properties of dorsal horn interneurons, as previously
suggested (Breton et al., 2009).
Here, we demonstrate that OT receptors are not only tonically
activated in inflammatory pain states but also inhibit spinal no-
ciceptive processing (Fig. 1B) and exert significant antihyperal-
gesia in carrageenan-induced pain model (Fig. 3). As shown by
the high number of OT neurons immunoreactive for FosB/
FosB, the elevated OT content in lumbar vertebral segments of
the spinal cord is likely to result from a sustained activation of
hypothalamospinal oxytocinergic axons. It is interesting to note
that the levels of OT in the blood, the CSF, and sometimes CNS
tissue (spinal cord and encephalon), are directly related to the
intensity of pain symptoms. Indeed, children exhibiting recur-
rent abdominal pain show reduced blood OT concentration
(Alfve´n et al., 1994), as well as in adult patients with lowback pain
(Yang, 1994). Recently, OT content was measured in the blood,
CSF, and lumbar spinal tissues collected from neuropathic rats
(Martínez-Lorenzana et al., 2008). OT concentration in the
blood and CSF of neuropathic rats was significantly lower com-
pared with control rats, whereas no change was observed in lum-
bar spinal tissues. In the carrageenan model of inflammatory
pain, we found that spinal OT contents are indeed elevated and
this difference is likely to be related to the inflammatory nature of
the painful stimulus and/or the moment where tissues were col-
lected and analyzed after pain induction. In good agreement, OT
content in the CSF is increased 24 h after a sciatic nerve loose
ligation and returned to control (pain free) values, 8 d later
(Martínez-Lorenzana et al., 2008). Unfortunately, there is no
similar time course for spinal OT available in the literature.
There is very little (and sometimes contradictory) informa-
tion regarding the intracellular molecular mechanisms recruited
by central OT receptor activation. Several reports are pointing
A2A1
B1 B2
Figure 3. Limitation of mechanical and thermal hyperalgesia in carrageenan-injected rats resulting from the stimulation 35 neurosteroid synthesis by endogenous oxytocin. A1, B1, Time
course of mechanical (pressure, A1) and thermal (heat, B1) nociceptive thresholds measured from the right (carrageenan-injected, black circle) hindpaw and the left (noninjected, open circles)
hindpaw. Thegraybar indicates values obtained24hafter the carrageenan injection,whichwill beusedas controls for the subsequent intrathecal injections (A2andB2). Two-wayANOVA (repeated
measures; time side) revealed a significant interaction for pressure and latency thresholds. Statistical differences are indicated after Bonferroni post hoc tests while comparing the thresholds
between side for a given time point (*p 0.05; **p 0.01; ***p 0.001). A2,B2, Mechanical and thermal nociceptive thresholds changes in carrageenan-injected hyperalgesic rats (24 h, gray
bar), assessedbefore (0 h) and after (1 and4h) intrathecal injection of saline, TGOT (100nM), or dOVT (1M). Three groups of ratswere used andpretreated 1weekbefore carrageenan injectionwith
subcutaneous vehicle (control, left graphs), finasteride (30mg/kg, middle graphs), or Depo-Provera (20mg/kg, right graphs). Note that dOVT-induced hyperalgesia (seen in control condition) was
never observed in finasterideorProvera-pretreatedanimals. Two-wayANOVA (repeatedmeasures, time treatment) revealeda significant interactiononly in the control condition forpressureand
latency thresholds. Statistical differences are indicated after Bonferroni post hoc tests while comparing the thresholds between groups for a given time point (***p 0.001 compared with saline)
and within time for each group ( §p 0.05; §§§p 0.001 compared with time 0).
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out the possiblemajor contribution ofmitogen-activated protein
kinases (MAPKs) in the control of pathological pain processes (Ji
et al., 2009). In line with this idea, anxiolysis produced by hypo-
thalamic infusion of OT was recently demonstrated to result
from the activation of ERK, a preeminent member of the MAPK
family (Blume et al., 2008). ERK activation in pain conditions
might promote long-lasting genomic changes but was also dem-
onstrated to change spinal neuron excitability (Hu and Gereau,
2003; Hu et al., 2003). In this study, we provide preliminary evi-
dence for a novel ERK-driven mechanism of analgesia, which
involves the stimulation of neurosteroidogenesis, more specifi-
cally the synthesis of the well known analgesic neurosteroid allo-
pregnanolone (Charlet et al., 2008). Interestingly, only the most
superficial layers and particularly the neurons in lamina II are
capable of producing allopregnanolone from cholesterol (In-
quimbert et al., 2008). Since the neurosteroid-mediated long-
lasting OT analgesia affects only C-type nociceptivemessages, we
can hypothesize that the increase of inhibitory tone is located in
this lamina highly innervated by C nociceptors. As observed in
Figure 3, we failed to observe any additional analgesic effect fol-
lowing TGOT administration. This leads us to suggest that 24 h
following induction of inflammation the neurosteroid synthesis
has reached its maximum. In a previously published paper (Pois-
beau et al., 2005), acute inhibition of neurosteroidogenesis by
finasteride (single injection 24 h before carrageenan injection)
was associated with a significant decrease of thermal hot but not
of mechanical nociceptive threshold. In this study, finasteride
treatment was without effect. Without knowing the underlying
mechanisms, we can only speculate that this might be due to
homeostatic compensation resulting from the repeated exposure
to finasteride (three injections every 2 d). How ERK activation
can stimulate neurosteroidogenesis in the CNS is still unknown.
The only available data refer to a possible steroidogenic role of
ERK in peripheral gonadic cells (Cameron et al., 1996; Das et al.,
1996; Gyles et al., 2001; Martinelle et al., 2004). Recently, a func-
tional interaction between ERK and the TSPO complex was sug-
gested (Poderoso et al., 2008, 2009). The contribution of ERK
could possibly be mediated by its binding to the steroidogenic
associated receptor protein, a major component of TSPO com-
plexes (cholesterol translocator protein complexes). This work-
ing hypothesis remains to be demonstrated in the spinal cord and
will require further investigations.
In summary, this study provides evidence indicating that in-
creased release of OT by hypothalamospinal axons in hyperalge-
sic rats, tonically activates lamina II dorsal horn spinal OT
receptors and, at least, the downstream intracellular effector
ERK1/2. Thismechanism leads to the stimulation of the synthesis
of analgesic neurosteroids. We demonstrate this novel mecha-
nism to be responsible for a sustained analgesic control in this
particular inflammatory pain model. Analgesia is apparently
achieved, at least, by an increase in the quantal inhibitory charge
carried by synaptic GABAA receptors in lamina II neurons, via an
allosteric potentiation by allopregnanolone-like neurosteroids.
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